篮球赔率

篮球赔率 Services FAQ Contact Us 0
Home Pharmaceuticals Autoimmune Therapeutics Market Size Projected to reach CAGR of 5.69% by 2033
Autoimmune Therapeutics Market

Autoimmune Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Immunosuppressants, Anti-inflammatory Drugs, Corticosteroids, Nonsteroidal Anti-Inflammatory Drugs, Biologics, Antihyperglycemics, Interferons, Others), By Disease Type (Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Multiple Sclerosis, Type 1 Diabetes, Inflammatory Bowel Disease, Psoriasis), By Distribution Channel (Hospitals Pharmacy, Clinics, Retail Pharmacies, Online Pharmacies, Drug Stores, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRPH907DR
Author : 篮球赔率
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Autoimmune Therapeutics Market Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Immunosuppressants
        1. By Value
      3. Anti-inflammatory Drugs
        1. By Value
      4. Corticosteroids
        1. By Value
      5. Nonsteroidal Anti-Inflammatory Drugs
        1. By Value
      6. Biologics
        1. By Value
      7. Antihyperglycemics
        1. By Value
      8. Interferons
        1. By Value
      9. Others
        1. By Value
    3. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Rheumatoid Arthritis
        1. By Value
      3. Systemic Lupus Erythematosus (SLE)
        1. By Value
      4. Multiple Sclerosis
        1. By Value
      5. Type 1 Diabetes
        1. By Value
      6. Inflammatory Bowel Disease
        1. By Value
      7. Psoriasis
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals Pharmacy 
        1. By Value
      3. Clinics
        1. By Value
      4. Retail Pharmacies
        1. By Value
      5. Online Pharmacies
        1. By Value
      6. Drug Stores 
        1. By Value
      7. Others
        1. By Value
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Immunosuppressants
        1. By Value
      3. Anti-inflammatory Drugs
        1. By Value
      4. Corticosteroids
        1. By Value
      5. Nonsteroidal Anti-Inflammatory Drugs
        1. By Value
      6. Biologics
        1. By Value
      7. Antihyperglycemics
        1. By Value
      8. Interferons
        1. By Value
      9. Others
        1. By Value
    3. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Rheumatoid Arthritis
        1. By Value
      3. Systemic Lupus Erythematosus (SLE)
        1. By Value
      4. Multiple Sclerosis
        1. By Value
      5. Type 1 Diabetes
        1. By Value
      6. Inflammatory Bowel Disease
        1. By Value
      7. Psoriasis
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals Pharmacy 
        1. By Value
      3. Clinics
        1. By Value
      4. Retail Pharmacies
        1. By Value
      5. Online Pharmacies
        1. By Value
      6. Drug Stores 
        1. By Value
      7. Others
        1. By Value
    5. U.S.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Immunosuppressants
          1. By Value
        3. Anti-inflammatory Drugs
          1. By Value
        4. Corticosteroids
          1. By Value
        5. Nonsteroidal Anti-Inflammatory Drugs
          1. By Value
        6. Biologics
          1. By Value
        7. Antihyperglycemics
          1. By Value
        8. Interferons
          1. By Value
        9. Others
          1. By Value
      2. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Rheumatoid Arthritis
          1. By Value
        3. Systemic Lupus Erythematosus (SLE)
          1. By Value
        4. Multiple Sclerosis
          1. By Value
        5. Type 1 Diabetes
          1. By Value
        6. Inflammatory Bowel Disease
          1. By Value
        7. Psoriasis
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals Pharmacy 
          1. By Value
        3. Clinics
          1. By Value
        4. Retail Pharmacies
          1. By Value
        5. Online Pharmacies
          1. By Value
        6. Drug Stores 
          1. By Value
        7. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Immunosuppressants
        1. By Value
      3. Anti-inflammatory Drugs
        1. By Value
      4. Corticosteroids
        1. By Value
      5. Nonsteroidal Anti-Inflammatory Drugs
        1. By Value
      6. Biologics
        1. By Value
      7. Antihyperglycemics
        1. By Value
      8. Interferons
        1. By Value
      9. Others
        1. By Value
    3. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Rheumatoid Arthritis
        1. By Value
      3. Systemic Lupus Erythematosus (SLE)
        1. By Value
      4. Multiple Sclerosis
        1. By Value
      5. Type 1 Diabetes
        1. By Value
      6. Inflammatory Bowel Disease
        1. By Value
      7. Psoriasis
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals Pharmacy 
        1. By Value
      3. Clinics
        1. By Value
      4. Retail Pharmacies
        1. By Value
      5. Online Pharmacies
        1. By Value
      6. Drug Stores 
        1. By Value
      7. Others
        1. By Value
    5. U.K.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Immunosuppressants
          1. By Value
        3. Anti-inflammatory Drugs
          1. By Value
        4. Corticosteroids
          1. By Value
        5. Nonsteroidal Anti-Inflammatory Drugs
          1. By Value
        6. Biologics
          1. By Value
        7. Antihyperglycemics
          1. By Value
        8. Interferons
          1. By Value
        9. Others
          1. By Value
      2. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Rheumatoid Arthritis
          1. By Value
        3. Systemic Lupus Erythematosus (SLE)
          1. By Value
        4. Multiple Sclerosis
          1. By Value
        5. Type 1 Diabetes
          1. By Value
        6. Inflammatory Bowel Disease
          1. By Value
        7. Psoriasis
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals Pharmacy 
          1. By Value
        3. Clinics
          1. By Value
        4. Retail Pharmacies
          1. By Value
        5. Online Pharmacies
          1. By Value
        6. Drug Stores 
          1. By Value
        7. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Immunosuppressants
        1. By Value
      3. Anti-inflammatory Drugs
        1. By Value
      4. Corticosteroids
        1. By Value
      5. Nonsteroidal Anti-Inflammatory Drugs
        1. By Value
      6. Biologics
        1. By Value
      7. Antihyperglycemics
        1. By Value
      8. Interferons
        1. By Value
      9. Others
        1. By Value
    3. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Rheumatoid Arthritis
        1. By Value
      3. Systemic Lupus Erythematosus (SLE)
        1. By Value
      4. Multiple Sclerosis
        1. By Value
      5. Type 1 Diabetes
        1. By Value
      6. Inflammatory Bowel Disease
        1. By Value
      7. Psoriasis
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals Pharmacy 
        1. By Value
      3. Clinics
        1. By Value
      4. Retail Pharmacies
        1. By Value
      5. Online Pharmacies
        1. By Value
      6. Drug Stores 
        1. By Value
      7. Others
        1. By Value
    5. China
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Immunosuppressants
          1. By Value
        3. Anti-inflammatory Drugs
          1. By Value
        4. Corticosteroids
          1. By Value
        5. Nonsteroidal Anti-Inflammatory Drugs
          1. By Value
        6. Biologics
          1. By Value
        7. Antihyperglycemics
          1. By Value
        8. Interferons
          1. By Value
        9. Others
          1. By Value
      2. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Rheumatoid Arthritis
          1. By Value
        3. Systemic Lupus Erythematosus (SLE)
          1. By Value
        4. Multiple Sclerosis
          1. By Value
        5. Type 1 Diabetes
          1. By Value
        6. Inflammatory Bowel Disease
          1. By Value
        7. Psoriasis
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals Pharmacy 
          1. By Value
        3. Clinics
          1. By Value
        4. Retail Pharmacies
          1. By Value
        5. Online Pharmacies
          1. By Value
        6. Drug Stores 
          1. By Value
        7. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Singapore
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Immunosuppressants
        1. By Value
      3. Anti-inflammatory Drugs
        1. By Value
      4. Corticosteroids
        1. By Value
      5. Nonsteroidal Anti-Inflammatory Drugs
        1. By Value
      6. Biologics
        1. By Value
      7. Antihyperglycemics
        1. By Value
      8. Interferons
        1. By Value
      9. Others
        1. By Value
    3. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Rheumatoid Arthritis
        1. By Value
      3. Systemic Lupus Erythematosus (SLE)
        1. By Value
      4. Multiple Sclerosis
        1. By Value
      5. Type 1 Diabetes
        1. By Value
      6. Inflammatory Bowel Disease
        1. By Value
      7. Psoriasis
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals Pharmacy 
        1. By Value
      3. Clinics
        1. By Value
      4. Retail Pharmacies
        1. By Value
      5. Online Pharmacies
        1. By Value
      6. Drug Stores 
        1. By Value
      7. Others
        1. By Value
    5. UAE
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Immunosuppressants
          1. By Value
        3. Anti-inflammatory Drugs
          1. By Value
        4. Corticosteroids
          1. By Value
        5. Nonsteroidal Anti-Inflammatory Drugs
          1. By Value
        6. Biologics
          1. By Value
        7. Antihyperglycemics
          1. By Value
        8. Interferons
          1. By Value
        9. Others
          1. By Value
      2. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Rheumatoid Arthritis
          1. By Value
        3. Systemic Lupus Erythematosus (SLE)
          1. By Value
        4. Multiple Sclerosis
          1. By Value
        5. Type 1 Diabetes
          1. By Value
        6. Inflammatory Bowel Disease
          1. By Value
        7. Psoriasis
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals Pharmacy 
          1. By Value
        3. Clinics
          1. By Value
        4. Retail Pharmacies
          1. By Value
        5. Online Pharmacies
          1. By Value
        6. Drug Stores 
          1. By Value
        7. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Immunosuppressants
        1. By Value
      3. Anti-inflammatory Drugs
        1. By Value
      4. Corticosteroids
        1. By Value
      5. Nonsteroidal Anti-Inflammatory Drugs
        1. By Value
      6. Biologics
        1. By Value
      7. Antihyperglycemics
        1. By Value
      8. Interferons
        1. By Value
      9. Others
        1. By Value
    3. By Disease Type
      1. Introduction
        1. Disease Type By Value
      2. Rheumatoid Arthritis
        1. By Value
      3. Systemic Lupus Erythematosus (SLE)
        1. By Value
      4. Multiple Sclerosis
        1. By Value
      5. Type 1 Diabetes
        1. By Value
      6. Inflammatory Bowel Disease
        1. By Value
      7. Psoriasis
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospitals Pharmacy 
        1. By Value
      3. Clinics
        1. By Value
      4. Retail Pharmacies
        1. By Value
      5. Online Pharmacies
        1. By Value
      6. Drug Stores 
        1. By Value
      7. Others
        1. By Value
    5. Brazil
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Immunosuppressants
          1. By Value
        3. Anti-inflammatory Drugs
          1. By Value
        4. Corticosteroids
          1. By Value
        5. Nonsteroidal Anti-Inflammatory Drugs
          1. By Value
        6. Biologics
          1. By Value
        7. Antihyperglycemics
          1. By Value
        8. Interferons
          1. By Value
        9. Others
          1. By Value
      2. By Disease Type
        1. Introduction
          1. Disease Type By Value
        2. Rheumatoid Arthritis
          1. By Value
        3. Systemic Lupus Erythematosus (SLE)
          1. By Value
        4. Multiple Sclerosis
          1. By Value
        5. Type 1 Diabetes
          1. By Value
        6. Inflammatory Bowel Disease
          1. By Value
        7. Psoriasis
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospitals Pharmacy 
          1. By Value
        3. Clinics
          1. By Value
        4. Retail Pharmacies
          1. By Value
        5. Online Pharmacies
          1. By Value
        6. Drug Stores 
          1. By Value
        7. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Autoimmune Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Roche Holding AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Pfizer Inc.
    3. Johnson & Johnson
    4. Abbott Laboratories
    5. Eli Lilly & Co.
    6. Biogen Inc.
    7. GlaxoSmithKline plc
    8. Merck & Co. Inc.
    9. Amgen Inc.
    10. AstraZeneca Plc
    11. Novartis AG
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global anti-VEGF therapeutics market size was valued at USD 12.3 billion in 2022. It is estimated to reach USD 13.7 billion by 2031, growing at a CAGR of 0.6% during the forecast period (2023–2031). The human body naturally produces VEGF,
Buy Now
Global Report
The global gastrointestinal therapeutics market size was valued at USD 70.92 billion in 2021, and it is anticipated to reach USD 125.42 billion by 2030 at a CAGR of 6.54%. A medical condition known as gastrointestinal (GI) syndrome disrupts the norm
Buy Now
Global Report
Melanoma Therapeutics Market Size The global melanoma therapeutics market size was valued at USD 8.65 billion in 2023. It is projected to reach USD 19.87 billion by 2032, growing at a CAGR of 10.80% during the forecast period (2024鈥�2032). Mela
Buy Now
Global Report
Microbiome Therapeutics Market Size The global microbiome therapeutics market size was valued at USD 591.85 million in 2024 and is expected to grow from USD 738.63 million in 2025 to USD 4346.54 million by 2033, growing at a CAGR
Buy Now
Global Report
Peptide Therapeutics Market Size & Trends The global peptide therapeutics market size was valued at USD 45.43 billion in 2023. It is projected to reach from USD 48.11 billion in 2025 to USD 76.11 billion by 2033, growing at a CAGR
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

篮球赔率
漏 Copyright . All rights Reserved.